Can Literature Review Automation Improve Healthcare Cost-Effectiveness Analysis and Budget Impact Modeling Outcomes?

Michael Broder, President, PHAR and Jesse Ortendhal, Director of Health Economics, PHAR give an overview on literature review automation in healthcare.

Scientists and researchers have never been busier. The post-COVID-19 world is driving a high-demand for evidence-based data to support healthcare decisions. An explosion in cost-effectiveness and budget impact modeling studies means systematic literature reviews need to be conducted faster, more accurately, and more efficiently while complying with specific requirements for transparency.

Watch to explore how automated workflows can help ensure screening, classification, and data management are performed faster and more accurately, streamlining the ability for researchers and decision makers to interpret these results and apply them to clinical practices.

Presenters

Michael Broder, MD, MSHS

President
Partnership for Health Analytic Research (PHAR)

Dr. Michael Broder has 30 years' experience in health economic and outcomes research. He has conducted dozens of expert panels on a wide variety of topics. In addition to being an experienced health services researcher, he is a board-certified physician and provides clinical expertise for many studies at PHAR.

Jesse Ortendahl, MS

Director
Health Economics
Partnership for Health Analytic Research (PHAR)

Jesse Ortendahl has a background in mathematics and statistics and has 20 years’ experience developing disease simulation models for economic evaluations. At PHAR, Jesse conducts and oversees health economic projects using both quantitative and qualitative methods. In addition to traditional cost effectiveness and budget impact models, Jesse has led studies with more policy-relevant goals, such as identifying flaws in current health technology assessment approaches, forecasting the burden of disease and potential policy levers to reduce that burden, and estimating the ramifications of payer policies on cost and clinical outcomes. His work spans a wide range of clinical areas including oncology, cardiology, pulmonology, neurology, and psychiatry.

Watch Webinar

Production Partner

Partnership for Health Analytic Research (PHAR)

PHAR brings together experienced methodologists and trained clinicians to produce high-quality real-world evidence that unlocks the hidden value of our clients’ innovative products.

VIEW PROFILE

Additional Content From Partnership for Health Analytic Research (PHAR)

Delphi Panels: What Are They Good For?

In this webinar, experts deep dive into Delphi panel methods, their implementation, and pharmaceutical industry insights on the panels' use and outcomes.

What Every Researcher Needs to Know About Using Medicare Data for Real World Evidence

Join three panelists who provide a practical overview of how and why to use data from Medicare for real world studies.

Achieving Consensus When Everyone is an Expert, but No One Agrees

Watch experts from PHAR, Novartis, and Bausch Health discuss the Delphi panels and how the results are used.

Related Content

Practical AI: Adding Insight to the Patient Journey with Digital Phenotyping

In this webinar, Dr. Joseph Zabinski will discuss the digital phenotyping process and several concrete applications to demonstrate how AI can add value to analyses of the patient journey across the life sciences spectrum.

The Scientific and Operational Elegance of Study Replication with Real-World EHR Data: A Vitiligo and Alopecia Example

This webinar, hosted by experts from Panalgo and OM1, will look at the scientific and operational details behind study replication, using vitiligo and alopecia areata as an example.

Insights from the 2024 Salary Survey Report by HealthEconomics.com

Keep your finger on the economic pulse of the RWE, HEOR, and Market Access fields. This session focuses on the latest salary and bonus trends for professionals in the field, including a comprehensive overview of the ways industry, job level, location, demographics, and more factor into compensation.